Tazarotene 0.05% w/w Gel

Tazarotene 0.05% w/w Gel is a topical retinoid used for plaque psoriasis and acne. It helps normalise abnormal skin-cell growth and reduce the thickening, scaling or clogged pores associated with these conditions.
Apply a thin layer to clean, completely dry affected skin, usually in the evening. Keep away from the eyes, lips, nostrils and eczematous or sunburned skin. Wash hands afterwards and use moisturiser and daytime sun protection to improve tolerability.
Tazarotene is converted in the skin to tazarotenic acid, which activates retinoic-acid receptors. This modifies skin-cell differentiation and inflammatory signalling.
Dryness, redness, peeling, burning and itching can occur, particularly early in treatment. Marked swelling, severe irritation or blistering needs treatment reassessment.
Do not use during pregnancy or while planning pregnancy because retinoids can harm the fetus. Avoid excessive UV exposure and harsh peeling or alcohol-based skin products. Applying more does not speed improvement and can cause substantial irritation.
Can reduce plaque scaling and thickness or improve acne lesions through targeted regulation of skin-cell turnover.
No. It is a vitamin A-related retinoid with a different mechanism and adverse-effect profile.
Wet or recently washed skin may be more easily irritated. Allow the area to dry before applying a thin layer.
Response develops over weeks. Using a larger amount to accelerate the result mainly increases irritation.
Strong exfoliants and drying products can intensify irritation, particularly while the skin is adapting.
Tazarotene is a retinoid with fetal-harm risk; topical use should not be treated as risk-free because it is applied to the skin.
Retinoid: a vitamin A-related medicine affecting cell growth. Plaque psoriasis: psoriasis with raised, scaly skin patches. Comedone: a blocked pore. Skin differentiation: maturation of skin cells; AR: Tazarotene 0.05% w/w جل; FR: Tazarotene 0.05% w/w gel; PT: Tazarotene 0.05% w/w gel; ES: Tazarotene 0.05% w/w gel; RU: Tazarotene 0.05% w/w гель; ID: Tazarotene 0.05% w/w gel; VI: Tazarotene 0.05% w/w gel bôi; MS: Tazarotene 0.05% w/w gel; TL: Tazarotene 0.05% w/w gel; ZH-SG: Tazarotene 0.05% w/w 凝胶
International B2B Enquiry
Send a structured B2B enquiry for Tazarotene 0.05% w/w Gel under Skin Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Tazarotene 0.05% w/w Gel